Premiumization and Strong Brands Fuel Constellation Brands' Growth

Constellation Brands, Inc. STZ maintains a strong position in the beer, wine and spirits market, supported by its premium-focused strategy, powerful brand portfolio and disciplined approach to portfolio management. The company offers a diverse range of premium, consumer-focused brands, including Modelo Especial, Corona Extra, Pacifico, Robert Mondavi Winery, Kim Crawford, The Prisoner Wine Company and High West. The strength of these brands positions Constellation Brands to capitalize on evolving consumer preferences and pursue opportunities across the global beverage alcohol market.

The company is focused on high-margin, high-growth segments of the beverage alcohol market, leveraging its direct-to-consumer capabilities and expanding global presence. Its flagship beer brands, including Modelo, Corona and Pacifico, remain important growth drivers and continue to strengthen its position in the U.S. beer market. The company is also investing in its Power Brands through brand-building initiatives, product innovation and new offerings designed to cater to evolving consumer preferences.

Constellation Brands has further sharpened its strategy around its core premium brands across beer, wine and spirits, with the goal of gaining market share, improving margins and driving sustainable long-term growth. Continued investments in brand building, strong beer business performance, premiumization, product innovation and cost-efficiency initiatives are expected to remain important growth and profitability drivers for Constellation Brands.

Hence, Constellation Brands is well-positioned in the beverage alcohol market, supported by its strong premium brand portfolio and focus on high-growth segments. Modelo, Corona and Pacifico remain key beer growth drivers, while brand building, premiumization, innovation and cost-efficiency initiatives are expected to support market share gains, margin expansion and long-term growth.

STZ’s Price Performance, Valuation & Estimates

Shares of Constellation Brands have lost 7.7% in the past three months against the industry’s growth of 4.1%.

Image Source: Zacks Investment Research

From a valuation standpoint, STZ trades at a forward price-to-earnings ratio of 10.7X compared with the industry’s average of 15.14X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for STZ’s fiscal 2027 and fiscal 2028 earnings per share (EPS) indicates year-over-year growth of 0.2% and 3.7%, respectively. The company’s EPS estimate for fiscal 2027 and fiscal 2028 has been stable in the past 30 days.

Image Source: Zacks Investment Research

Constellation Brands stock currently carries a Zacks Rank #3 (Hold).

Key Consumer Staple Picks

The Chef's Warehouse CHEF, which is a distributor of specialty food and center-of-the-plate products across the United States, Canada and the Middle East, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.  

The Zacks Consensus Estimate for CHEF’s current-year sales indicates growth of 10.6% from the prior-year level. CHEFdelivered a trailing four-quarter earnings surprise of 30.4%, on average.

Medifast, Inc. MED, which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank #2 (Buy). MED missed the average earnings surprise by a sharp margin in the trailing four quarters.

The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 27.3% from the year-ago number. 

United Natural Foods UNFI, which is the leading distributor of natural, organic and specialty food and non-food products, currently has a Zacks Rank of 2. 

The Zacks Consensus Estimate for United Natural Foods’ current financial-year sales indicates a drop of 2.1% from the prior-year level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
 

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research